Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
These elevated levels reflect successful absorption and distribution of the vitamin into the bloodstream, where it can be utilized by tissues (source: National Institutes of Health)
Dazu reicht eine formlose Mitteilung per E-Mail an uns
NIH has released four new SBIR/STTR solicitations (first deadline for all solicitations is September 8, 2026): Parent SBIR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track SBIR awards Parent STTR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track STTR awards SBIR Phase IIB Strategic Breakthrough Award (Clinical Trial Optional) accepts Phase IIB Strategic Breakthrough SBIR awards (for Phase II awardees) SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Clinical Trial Optional) accepts CRP awards (for Phase II awardees) Updated summaries of the research interests, budget waiver topics, and award mechanisms supported by individual Institutes and Centers (ICs) are now housed on the Small Business Funding Considerations and Contacts webpage
Swertia japonica extract anti-inflammatory and antioxidant support Swertia japonica is a plant used in traditional Japanese medicine
liposomes help to protect this antioxidant providing greater amounts to the body
We note that these changes can be a result of different factors, including updated data, payment weight changes, and changes in policy
US$ 28.62
US$ 20.38
US$ 27.21
US$ 23.11
/assets/images/provider/photos/2718484.jpeg)
